# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000320017-23-000011
Filing Date
2023-03-30
Accepted
2023-03-30 16:09:20
Documents
205
Period of Report
2022-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-K | clbs-20221231.htm iXBRL | 10-K | 1704112
2 | EX-10.1 | ex101to10-k20222131.htm | EX-10.1 | 12242
3 | EX-10.2 | ex102-lisatatherapeutics.htm | EX-10.2 | 78907
4 | EX-10.3 | ex1032018equityincentive.htm | EX-10.3 | 239201
5 | EX-10.4 | ex104-2015equitycompensa.htm | EX-10.4 | 92836
6 | EX-10.5 | ex105-amendedrestated200.htm | EX-10.5 | 71138
7 | EX-10.25 | ex1025clawbackpolicy.htm | EX-10.25 | 30566
8 | EX-14.1 | ex14110-k20221231.htm | EX-14.1 | 26887
9 | EX-21.1 | ex211to10k20221231.htm | EX-21.1 | 10477
10 | EX-23.1 | exh2312022.htm | EX-23.1 | 3187
11 | EX-31.1 | clbs-ex311_20221231xq4.htm | EX-31.1 | 9067
12 | EX-32 | clbs-ex32_20221231.htm | EX-32 | 6172
18 |  | clbs-20221231_g1.jpg | GRAPHIC | 158919
19 |  | ex102-lisatatherapeutics001.jpg | GRAPHIC | 286232
20 |  | ex102-lisatatherapeutics002.jpg | GRAPHIC | 270564
21 |  | ex102-lisatatherapeutics003.jpg | GRAPHIC | 290676
22 |  | ex102-lisatatherapeutics004.jpg | GRAPHIC | 317432
23 |  | ex102-lisatatherapeutics005.jpg | GRAPHIC | 335694
24 |  | ex102-lisatatherapeutics006.jpg | GRAPHIC | 288553
25 |  | ex102-lisatatherapeutics007.jpg | GRAPHIC | 367936
26 |  | ex102-lisatatherapeutics008.jpg | GRAPHIC | 306038
27 |  | ex102-lisatatherapeutics009.jpg | GRAPHIC | 337610
28 |  | ex102-lisatatherapeutics010.jpg | GRAPHIC | 309079
29 |  | ex102-lisatatherapeutics011.jpg | GRAPHIC | 360482
30 |  | ex102-lisatatherapeutics012.jpg | GRAPHIC | 328738
31 | GRAPHIC | ex102-lisatatherapeutics013.jpg | GRAPHIC | 301470
32 | GRAPHIC | ex102-lisatatherapeutics014.jpg | GRAPHIC | 352501
33 | GRAPHIC | ex102-lisatatherapeutics015.jpg | GRAPHIC | 192090
34 |  | ex1032018equityincentive001.jpg | GRAPHIC | 198822
35 |  | ex1032018equityincentive002.jpg | GRAPHIC | 244766
36 |  | ex1032018equityincentive003.jpg | GRAPHIC | 212750
37 |  | ex1032018equityincentive004.jpg | GRAPHIC | 218878
38 |  | ex1032018equityincentive005.jpg | GRAPHIC | 228499
39 |  | ex1032018equityincentive006.jpg | GRAPHIC | 236471
40 |  | ex1032018equityincentive007.jpg | GRAPHIC | 247185
41 |  | ex1032018equityincentive008.jpg | GRAPHIC | 274131
42 |  | ex1032018equityincentive009.jpg | GRAPHIC | 236683
43 |  | ex1032018equityincentive010.jpg | GRAPHIC | 270172
44 |  | ex1032018equityincentive011.jpg | GRAPHIC | 317019
45 |  | ex1032018equityincentive012.jpg | GRAPHIC | 207277
46 |  | ex1032018equityincentive013.jpg | GRAPHIC | 294116
47 |  | ex1032018equityincentive014.jpg | GRAPHIC | 290370
48 |  | ex1032018equityincentive015.jpg | GRAPHIC | 272520
49 |  | ex1032018equityincentive016.jpg | GRAPHIC | 257388
50 |  | ex1032018equityincentive017.jpg | GRAPHIC | 287007
51 |  | ex1032018equityincentive018.jpg | GRAPHIC | 230618
52 |  | ex1032018equityincentive019.jpg | GRAPHIC | 241659
53 |  | ex1032018equityincentive020.jpg | GRAPHIC | 221205
54 |  | ex1032018equityincentive021.jpg | GRAPHIC | 235385
55 |  | ex1032018equityincentive022.jpg | GRAPHIC | 319163
56 |  | ex1032018equityincentive023.jpg | GRAPHIC | 229899
57 |  | ex1032018equityincentive024.jpg | GRAPHIC | 298208
58 |  | ex1032018equityincentive025.jpg | GRAPHIC | 276533
59 |  | ex1032018equityincentive026.jpg | GRAPHIC | 300385
60 |  | ex1032018equityincentive027.jpg | GRAPHIC | 298698
61 |  | ex1032018equityincentive028.jpg | GRAPHIC | 317500
62 |  | ex1032018equityincentive029.jpg | GRAPHIC | 293768
63 |  | ex1032018equityincentive030.jpg | GRAPHIC | 362596
64 |  | ex1032018equityincentive031.jpg | GRAPHIC | 298695
65 |  | ex1032018equityincentive032.jpg | GRAPHIC | 343151
66 |  | ex1032018equityincentive033.jpg | GRAPHIC | 329521
67 |  | ex1032018equityincentive034.jpg | GRAPHIC | 336405
68 |  | ex1032018equityincentive035.jpg | GRAPHIC | 311636
69 |  | ex1032018equityincentive036.jpg | GRAPHIC | 301733
70 |  | ex1032018equityincentive037.jpg | GRAPHIC | 337475
71 |  | ex1032018equityincentive038.jpg | GRAPHIC | 297364
72 |  | ex1032018equityincentive039.jpg | GRAPHIC | 246741
73 |  | ex1032018equityincentive040.jpg | GRAPHIC | 275430
74 |  | ex1032018equityincentive041.jpg | GRAPHIC | 277395
75 |  | ex1032018equityincentive042.jpg | GRAPHIC | 274961
76 |  | ex1032018equityincentive043.jpg | GRAPHIC | 273255
77 |  | ex1032018equityincentive044.jpg | GRAPHIC | 307307
78 |  | ex1032018equityincentive045.jpg | GRAPHIC | 290037
79 |  | ex1032018equityincentive046.jpg | GRAPHIC | 332971
80 |  | ex1032018equityincentive047.jpg | GRAPHIC | 280360
81 |  | ex1032018equityincentive048.jpg | GRAPHIC | 344588
82 |  | ex1032018equityincentive049.jpg | GRAPHIC | 279756
83 |  | ex1032018equityincentive050.jpg | GRAPHIC | 338092
84 |  | ex1032018equityincentive051.jpg | GRAPHIC | 285125
85 |  | ex1032018equityincentive052.jpg | GRAPHIC | 269655
86 |  | ex1032018equityincentive053.jpg | GRAPHIC | 295603
87 |  | ex1032018equityincentive054.jpg | GRAPHIC | 355860
88 |  | ex104-2015equitycompensa001.jpg | GRAPHIC | 249891
89 |  | ex104-2015equitycompensa002.jpg | GRAPHIC | 235993
90 |  | ex104-2015equitycompensa003.jpg | GRAPHIC | 209186
91 |  | ex104-2015equitycompensa004.jpg | GRAPHIC | 266534
92 |  | ex104-2015equitycompensa005.jpg | GRAPHIC | 237803
93 |  | ex104-2015equitycompensa006.jpg | GRAPHIC | 235407
94 |  | ex104-2015equitycompensa007.jpg | GRAPHIC | 283665
95 |  | ex104-2015equitycompensa008.jpg | GRAPHIC | 294113
96 |  | ex104-2015equitycompensa009.jpg | GRAPHIC | 256270
97 |  | ex104-2015equitycompensa010.jpg | GRAPHIC | 361936
98 |  | ex104-2015equitycompensa011.jpg | GRAPHIC | 235090
99 |  | ex104-2015equitycompensa012.jpg | GRAPHIC | 312629
100 |  | ex104-2015equitycompensa013.jpg | GRAPHIC | 314498
101 |  | ex104-2015equitycompensa014.jpg | GRAPHIC | 277455
102 |  | ex104-2015equitycompensa015.jpg | GRAPHIC | 310851
103 |  | ex104-2015equitycompensa016.jpg | GRAPHIC | 296534
104 |  | ex104-2015equitycompensa017.jpg | GRAPHIC | 288061
105 |  | ex104-2015equitycompensa018.jpg | GRAPHIC | 279812
106 |  | ex104-2015equitycompensa019.jpg | GRAPHIC | 316598
107 |  | ex104-2015equitycompensa020.jpg | GRAPHIC | 315821
108 |  | ex104-2015equitycompensa021.jpg | GRAPHIC | 150942
109 |  | ex104-2015equitycompensa022.jpg | GRAPHIC | 221824
110 |  | ex104-2015equitycompensa023.jpg | GRAPHIC | 229249
111 |  | ex105-amendedrestated200001.jpg | GRAPHIC | 266083
112 |  | ex105-amendedrestated200002.jpg | GRAPHIC | 245348
113 |  | ex105-amendedrestated200003.jpg | GRAPHIC | 196855
114 |  | ex105-amendedrestated200004.jpg | GRAPHIC | 245711
115 |  | ex105-amendedrestated200005.jpg | GRAPHIC | 241932
116 |  | ex105-amendedrestated200006.jpg | GRAPHIC | 311124
117 |  | ex105-amendedrestated200007.jpg | GRAPHIC | 259946
118 |  | ex105-amendedrestated200008.jpg | GRAPHIC | 345286
119 |  | ex105-amendedrestated200009.jpg | GRAPHIC | 263457
120 |  | ex105-amendedrestated200010.jpg | GRAPHIC | 288440
121 |  | ex105-amendedrestated200011.jpg | GRAPHIC | 291862
122 |  | ex105-amendedrestated200012.jpg | GRAPHIC | 284876
123 |  | ex105-amendedrestated200013.jpg | GRAPHIC | 321591
124 |  | ex105-amendedrestated200014.jpg | GRAPHIC | 268581
125 |  | ex105-amendedrestated200015.jpg | GRAPHIC | 254068
126 |  | ex105-amendedrestated200016.jpg | GRAPHIC | 252728
127 |  | ex105-amendedrestated200017.jpg | GRAPHIC | 222644
128 |  | ex105-amendedrestated200018.jpg | GRAPHIC | 228094
129 |  | image.jpg | GRAPHIC | 21441
| Complete submission text file | 0000320017-23-000011.txt |  | 51182128

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
13 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | clbs-20221231.xsd | EX-101.SCH | 58165
14 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | clbs-20221231_cal.xml | EX-101.CAL | 83260
15 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | clbs-20221231_def.xml | EX-101.DEF | 182255
16 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | clbs-20221231_lab.xml | EX-101.LAB | 723226
17 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | clbs-20221231_pre.xml | EX-101.PRE | 440176
199 | EXTRACTED XBRL INSTANCE DOCUMENT | clbs-20221231_htm.xml | XML | 964444

Mailing Address 110 ALLEN ROAD SECOND FLOOR BASKING RIDGE NJ 07920
Business Address 110 ALLEN ROAD SECOND FLOOR BASKING RIDGE NJ 07920 908-229-2590
LISATA THERAPEUTICS, INC. (Filer) CIK: 0000320017 (see all company filings)

EIN.: 222343568 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33650 | Film No.: 23780764
SIC: 8090 Services-Misc Health & Allied Services, NEC